Effective transduction by self-complementary adeno-associated viruses of human dendritic cells with no alteration of their natural characteristics

被引:16
作者
Shin, Ohkyu [1 ]
Kim, Sung Jin [1 ]
Lee, Won Il [1 ]
Kim, Jee Yeon [1 ]
Lee, Heuiran [1 ,2 ]
机构
[1] Univ Ulsan, Coll Med, Dept Microbiol, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Res Inst Biomacromol, Seoul 138736, South Korea
关键词
dendritic cell; maturation; recombinant adeno-associated virus; serotype; transduction efficiency;
D O I
10.1002/jgm.1204
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Effective gene delivery techniques are required to genetically manipulate dendritic cells (DCs). We therefore investigated the feasibility of using various self-complementary recombinant adeno-associated virus (scAAV) serotypes to deliver genes to human DCs. Methods Monocytes isolated from healthy volunteers were differentiated to immature DCs (iDC) by incubation with interleukin (IL)-4 and granulocyte macrophage colony-stimulating factor. The iDCs were transduced with scAAV1, 2, 3, 4, 5, 6 or 8 at various multiplicities of infection (MOIs). Transduction efficiency (TE), cell viability and functional characteristics of the transduced DCs were evaluated. Results TE of scAAV was three-fold greater than TE of conventional recombinant adeno-associated virus with a single-stranded genome. The TEs of scAAV2, 5, and 6 were much higher than those of the other scAAVs; at 1000 MOL the TEs were 22.2% +/- 9.5%, 27.0% +/- 8.8% and 28.4% +/- 6.0%, respectively. Exposure of iDCs to 5000 MOI of these viruses increased their TEs, leading to the transduction of nearly the entire DC population. In addition, gene transfer by scAAV did not cause any cytotoxicity. Flow cytometric analysis of scAAV-transduced DCs showed no changes in surface marker profiles. Moreover, transduced cells maintained their functional properties, as represented by active antigen uptake. These cells could efficiently differentiate into mature DCs, as shown by their release of IL-12, the substantial loss of antigen-uptake activity, and the ability of T-cell stimulation. Conclusions These findings strongly indicate that scAAVs, especially subtypes 2, 5 and 6, hold a promising potential as gene delivery tools in human DCs. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:762 / 769
页数:8
相关论文
共 38 条
  • [1] Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands
    Aldrich, WA
    Ren, C
    White, AF
    Zhou, SZ
    Kumar, S
    Jenkins, CB
    Shaw, DR
    Strong, TV
    Triozzi, PL
    Ponnazhagan, S
    [J]. GENE THERAPY, 2006, 13 (01) : 29 - 39
  • [2] Dendritic cells as vectors for therapy
    Banchereau, J
    Schuler-Thurner, B
    Palucka, AK
    Schuler, G
    [J]. CELL, 2001, 106 (03) : 271 - 274
  • [3] Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
    Blankinship, MJ
    Gregorevic, P
    Allen, JM
    Harper, SQ
    Harper, H
    Halbert, CL
    Miller, AD
    Chamberlain, JS
    [J]. MOLECULAR THERAPY, 2004, 10 (04) : 671 - 678
  • [4] Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors
    Chen, SF
    Kapturczak, M
    Loiler, SA
    Zolotukhin, S
    Glushakova, OY
    Madsen, KM
    Samulski, RJ
    Hauswirth, WW
    Campbell-Thompson, M
    Berns, KI
    Flotte, TR
    Atkinson, MA
    Tisher, CC
    Agarwal, A
    [J]. HUMAN GENE THERAPY, 2005, 16 (02) : 235 - 247
  • [5] Dendritic cell immunotherapy: mapping the way
    Figdor, CG
    de Vries, IJM
    Lesterhuis, WJ
    Melief, CJM
    [J]. NATURE MEDICINE, 2004, 10 (05) : 475 - 480
  • [6] Gene therapy progress and prospects: Recombinant adeno-associated virus (rAAV) vectors
    Flotte, TR
    [J]. GENE THERAPY, 2004, 11 (10) : 805 - 810
  • [7] Adeno-associated virus: from defective virus to effective vector
    Goncalves, Manuel A. F. V.
    [J]. VIROLOGY JOURNAL, 2005, 2 (1)
  • [8] Packaging capacity of adeno-associated virus serotypes: Impact of larger genomes on infectivity and postentry steps
    Grieger, JC
    Samulski, RJ
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (15) : 9933 - 9944
  • [9] Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors
    Halbert, CL
    Allen, JM
    Miller, AD
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (14) : 6615 - 6624
  • [10] Murine dendritic cells infected with adenovirus vectors show signs of activation
    Hirschowitz, EA
    Weaver, JD
    Hidalgo, GE
    Doherty, DE
    [J]. GENE THERAPY, 2000, 7 (13) : 1112 - 1120